Senescence in tumours: evidence from mice and humans
The importance of cellular senescence, which is a stress response that stably blocks proliferation, is increasingly being recognized. Senescence is prevalent in pre-malignant tumours, and progression to malignancy requires evading senescence. Malignant tumours, however, may still undergo senescence...
| Autores: | , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión aceptada para publicación |
| Fecha de publicación: | 2010 |
| País: | España |
| Institución: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repositorio: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/345057 |
| Acceso en línea: | http://hdl.handle.net/10261/345057 |
| Access Level: | acceso abierto |
| Palabra clave: | Oncogenes Senescence Tumour suppressors |
| id |
ES_377e6040e2cd61ee5f89d4c3d3143d8a |
|---|---|
| oai_identifier_str |
oai:digital.csic.es:10261/345057 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Senescence in tumours: evidence from mice and humansCollado, ManuelSerrano, ManuelOncogenesSenescenceTumour suppressorsThe importance of cellular senescence, which is a stress response that stably blocks proliferation, is increasingly being recognized. Senescence is prevalent in pre-malignant tumours, and progression to malignancy requires evading senescence. Malignant tumours, however, may still undergo senescence owing to interventions that restore tumour suppressor function or inactivate oncogenes. Senescent tumour cells can be cleared by immune cells, which may result in efficient tumour regression. Standard chemotherapy also has the potential to induce senescence, which may partly underlie its therapeutic activity. Although these concepts are well supported in mouse models, translating them to clinical oncology remains a challenge.Work in the authors' laboratory is funded by the Spanish National Cancer Research Centre, the Spanish Ministry of Science, the Regional Government of Madrid, the European Union (PROTEOMAGE), the European Research Council and the Marcelino Botin Foundation.Peer reviewedMacmillan PublishersCentro Nacional de Investigaciones Oncológicas (España)Ministerio de Ciencia e Innovación (España)Comunidad de MadridEuropean Research Council202420242010info:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_6501Postprintinfo:eu-repo/semantics/acceptedVersionapplication/pdfhttp://hdl.handle.net/10261/345057reponame:DIGITAL.CSIC. Repositorio Institucional del CSICinstname:Consejo Superior de Investigaciones Científicas (CSIC)Ingléshttps://doi.org/10.1038/nrc2772Noinfo:eu-repo/semantics/openAccessoai:digital.csic.es:10261/3450572026-05-22T06:33:51Z |
| dc.title.none.fl_str_mv |
Senescence in tumours: evidence from mice and humans |
| title |
Senescence in tumours: evidence from mice and humans |
| spellingShingle |
Senescence in tumours: evidence from mice and humans Collado, Manuel Oncogenes Senescence Tumour suppressors |
| title_short |
Senescence in tumours: evidence from mice and humans |
| title_full |
Senescence in tumours: evidence from mice and humans |
| title_fullStr |
Senescence in tumours: evidence from mice and humans |
| title_full_unstemmed |
Senescence in tumours: evidence from mice and humans |
| title_sort |
Senescence in tumours: evidence from mice and humans |
| dc.creator.none.fl_str_mv |
Collado, Manuel Serrano, Manuel |
| author |
Collado, Manuel |
| author_facet |
Collado, Manuel Serrano, Manuel |
| author_role |
author |
| author2 |
Serrano, Manuel |
| author2_role |
author |
| dc.contributor.none.fl_str_mv |
Centro Nacional de Investigaciones Oncológicas (España) Ministerio de Ciencia e Innovación (España) Comunidad de Madrid European Research Council |
| dc.subject.none.fl_str_mv |
Oncogenes Senescence Tumour suppressors |
| topic |
Oncogenes Senescence Tumour suppressors |
| description |
The importance of cellular senescence, which is a stress response that stably blocks proliferation, is increasingly being recognized. Senescence is prevalent in pre-malignant tumours, and progression to malignancy requires evading senescence. Malignant tumours, however, may still undergo senescence owing to interventions that restore tumour suppressor function or inactivate oncogenes. Senescent tumour cells can be cleared by immune cells, which may result in efficient tumour regression. Standard chemotherapy also has the potential to induce senescence, which may partly underlie its therapeutic activity. Although these concepts are well supported in mouse models, translating them to clinical oncology remains a challenge. |
| publishDate |
2010 |
| dc.date.none.fl_str_mv |
2010 2024 2024 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_6501 Postprint info:eu-repo/semantics/acceptedVersion |
| format |
article |
| status_str |
acceptedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/10261/345057 |
| url |
http://hdl.handle.net/10261/345057 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
https://doi.org/10.1038/nrc2772 No |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Macmillan Publishers |
| publisher.none.fl_str_mv |
Macmillan Publishers |
| dc.source.none.fl_str_mv |
reponame:DIGITAL.CSIC. Repositorio Institucional del CSIC instname:Consejo Superior de Investigaciones Científicas (CSIC) |
| instname_str |
Consejo Superior de Investigaciones Científicas (CSIC) |
| reponame_str |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| collection |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869406040968134656 |
| score |
15,811543 |